"We set out to systematically investigate global sequencing databases for a signature of #molnupiravir #mutagenesis. We find that a specific class of long phylogenetic branches appear almost exclusively in sequences from 2022, after the introduction of molnupiravir treatment, and in countries and age-groups with widespread usage of the drug."

#Preprint #COVID19 #Covid #Antiviral #SARSCoV2

https://www.medrxiv.org/content/10.1101/2023.01.26.23284998v1